OurMind
Develops AI software that helps healthcare organizations reduce administrative workloads and free clinicians to focus on patient care.
Overview
OurMind builds AI tools for healthcare administration, addressing the operational burden that consumes clinical and organizational time. Its target market is healthcare providers and teams seeking to streamline non-clinical workflows and improve staff productivity. The Amsterdam-based company is positioned around a focused use case: applying AI to reduce healthcare admin work rather than broader clinical decision-making. OurMind has raised about €2 million in an undisclosed round to support development and growth.
Funding History
Amsterdam’s OurMind raises €2.1 million to reduce healthcare admin burden with AI
Frequently Asked Questions
- How much funding does AI Funding track for OurMind?
- AI Funding tracks €2M for OurMind across 1 funding round in this database.
- Who are OurMind's investors?
- OurMind's investors include 4impact capital.
- What does OurMind do?
- OurMind builds AI tools for healthcare administration, addressing the operational burden that consumes clinical and organizational time. Its target market is healthcare providers and teams seeking to streamline non-clinical workflows and improve staff productivity. The Amsterdam-based company is positioned around a focused use case: applying AI to reduce healthcare admin work rather than broader clinical decision-making. OurMind has raised about €2 million in an undisclosed round to support development and growth.
- Where is OurMind headquartered?
- OurMind is headquartered in Amsterdam, Netherlands.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.